Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …

Acinetobacter baumannii is a Gram-negative opportunistic bacterium responsible for
nosocomial and community-acquired infections. This pathogen is globally disseminated and …

Antibacterial resistance is a renewed public health plague in modern times, and the COVID-
19 pandemic has rekindled this problem. Changes in antibiotic prescribing behavior …

Acinetobacter baumannii is one of the key Gram-negative pathogens that can cause serious
nosocomial infections. In China, a large proportion of clinical A. baumannii strains are …

Acinetobacter baumannii is a nosocomial pathogen responsible for several serious
infections, including pneumonia, sepsis, and meningitis. The propensity of this bacterium to …

Acinetobacter baumannii is a common cause of healthcare-associated infections and
hospital outbreaks, particularly in intensive care units. Much of the success of A. baumannii …

Introduction Non-baumannii Acinetobacter species are increasingly isolated in the clinical
setting and the environment. The aim of the present study was to analyze a genome …

Carbapenems have been considered to be the preferred antibiotics against Acinetobacter
baumannii thus far. However, carbapenem-resistant Acinetobacter baumannii (CRAB) has …

Clinical antibiotics used worldwide could diminish the intestinal barrier, enhance contact
with microbiota and intestinal immune cells, and induce inflammation. We found that …

Acinetobacter baumannii is a gram-negative bacillus prevalent in nature, capable of thriving
under various environmental conditions. As an opportunistic pathogen, it frequently causes …